These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20484050)

  • 1. Inhibition of thrombin formation by active site mutated (S360A) activated protein C.
    Nicolaes GA; Bock PE; Segers K; Wildhagen KC; Dahlbäck B; Rosing J
    J Biol Chem; 2010 Jul; 285(30):22890-900. PubMed ID: 20484050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein C.
    Yegneswaran S; Nguyen PM; Gale AJ; Griffin JH
    Thromb Haemost; 2009 Jan; 101(1):55-61. PubMed ID: 19132189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gly74Ser mutation in protein C causes thrombosis due to a defect in protein S-dependent anticoagulant function.
    Chen C; Yang L; Villoutreix BO; Wang X; Ding Q; Rezaie AR
    Thromb Haemost; 2017 Jun; 117(7):1358-1369. PubMed ID: 28405673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonenzymatic anticoagulant activity of the mutant serine protease Ser360Ala-activated protein C mediated by factor Va.
    Gale AJ; Sun X; Heeb MJ; Griffin JH
    Protein Sci; 1997 Jan; 6(1):132-40. PubMed ID: 9007985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor Va is inactivated by activated protein C in the absence of cleavage sites at Arg-306, Arg-506, and Arg-679.
    van der Neut Kolfschoten M; Dirven RJ; Vos HL; Tans G; Rosing J; Bertina RM
    J Biol Chem; 2004 Feb; 279(8):6567-75. PubMed ID: 14660667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of an extended binding site for coagulation factor Va in the positive exosite of activated protein C.
    Gale AJ; Tsavaler A; Griffin JH
    J Biol Chem; 2002 Aug; 277(32):28836-40. PubMed ID: 12063259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex.
    Gierula M; Salles-Crawley II; Santamaria S; Teraz-Orosz A; Crawley JTB; Lane DA; Ahnström J
    J Thromb Haemost; 2019 Dec; 17(12):2056-2068. PubMed ID: 31364267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced rate of cleavage at Arg-306 and Arg-506 in coagulation factor Va by Gla domain-mutated human-activated protein C.
    Sun YH; Tran S; Norstrøm EA; Dahlbäck B
    J Biol Chem; 2004 Nov; 279(46):47528-35. PubMed ID: 15337738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a factor Xa binding site on factor Va near the Arg-506 activated protein C cleavage site.
    Gale AJ; Yegneswaran S; Xu X; Pellequer JL; Griffin JH
    J Biol Chem; 2007 Jul; 282(30):21848-55. PubMed ID: 17553804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor Va residues 311-325 represent an activated protein C binding region.
    Yegneswaran S; Kojima Y; Nguyen PM; Gale AJ; Heeb MJ; Griffin JH
    J Biol Chem; 2007 Sep; 282(39):28353-28361. PubMed ID: 17646160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
    Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
    Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The C-terminal region of the factor V B-domain is crucial for the anticoagulant activity of factor V.
    Thorelli E; Kaufman RJ; Dahlbäck B
    J Biol Chem; 1998 Jun; 273(26):16140-5. PubMed ID: 9632668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V.
    Thorelli E; Kaufman RJ; Dahlbäck B
    Blood; 1999 Apr; 93(8):2552-8. PubMed ID: 10194434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms that regulate the anticoagulant function of coagulation factor V.
    Thorelli E
    Scand J Clin Lab Invest Suppl; 1999; 229():19-26. PubMed ID: 10097286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary substrate-binding exosite in the serine protease domain of activated protein C important for cleavage at Arg-506 but not at Arg-306 in factor Va.
    Friedrich U; Nicolaes GA; Villoutreix BO; Dahlbäck B
    J Biol Chem; 2001 Jun; 276(25):23105-8. PubMed ID: 11309403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prothrombin on the individual activated protein C-mediated cleavages of coagulation factor Va.
    Tran S; Norstrøm E; Dahlbäck B
    J Biol Chem; 2008 Mar; 283(11):6648-55. PubMed ID: 18198180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein C.
    Gale AJ; Xu X; Pellequer JL; Getzoff ED; Griffin JH
    Protein Sci; 2002 Sep; 11(9):2091-101. PubMed ID: 12192065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C4b-binding protein protects coagulation factor Va from inactivation by activated protein C.
    van de Poel RH; Meijers JC; Rosing J; Tans G; Bouma BN
    Biochemistry; 2000 Nov; 39(47):14543-8. PubMed ID: 11087409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The autolysis loop of activated protein C interacts with factor Va and differentiates between the Arg506 and Arg306 cleavage sites.
    Gale AJ; Heeb MJ; Griffin JH
    Blood; 2000 Jul; 96(2):585-93. PubMed ID: 10887122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparin.
    Segers K; Dahlbäck B; Rosing J; Nicolaes GA
    J Biol Chem; 2008 Aug; 283(33):22573-81. PubMed ID: 18519572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.